| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |